000504 *ST南華生物
按盤價 
9.040 +0.230 (+2.611%)
9.040 +0.230 (+2.611%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.183 | -8.034 | -20.795 | -81.291 | -88.528 |
| 總資產報酬率 ROA (%) | 0.722 | -2.877 | -4.253 | -2.055 | -3.147 |
| 投入資產回報率 ROIC (%) | 1.015 | -4.413 | -8.426 | -6.075 | -12.780 | 邊際利潤分析 |
| 銷售毛利率 (%) | 63.425 | 67.416 | 68.063 | 64.792 | 70.831 |
| 營業利潤率 (%) | -2.974 | -15.481 | -33.419 | -13.052 | -19.579 |
| 息稅前利潤/營業總收入 (%) | -3.963 | -15.686 | -26.025 | -4.978 | -10.368 |
| 淨利潤/營業總收入 (%) | -3.775 | -17.795 | -34.198 | -14.704 | -21.135 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 128.226 | 16.196 | 46.053 | 32.101 | 62.241 |
| 價值變動淨收益/利潤總額(%) | -165.831 | -17.662 | -2.133 | 0.255 | 1.033 |
| 營業外收支淨額/利潤總額(%) | 20.246 | 0.180 | -2.246 | -21.290 | -1.447 | 償債能力分析 |
| 流動比率 (X) | 1.420 | 1.316 | 1.448 | 0.915 | 0.977 |
| 速動比率 (X) | 1.293 | 1.204 | 1.424 | 0.905 | 0.956 |
| 資產負債率 (%) | 56.927 | 53.632 | 60.503 | 85.509 | 83.266 |
| 帶息債務/全部投入資本 (%) | 51.813 | 44.276 | 40.105 | 85.157 | 81.178 |
| 股東權益/帶息債務 (%) | 79.980 | 119.935 | 141.467 | 7.621 | 10.552 |
| 股東權益/負債合計 (%) | 50.559 | 72.690 | 55.054 | 2.961 | 3.031 |
| 利息保障倍數 (X) | 16.897 | 88.422 | -3.907 | -0.861 | -1.161 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 449.461 | 351.848 | 371.056 | 318.839 | 442.373 |
| 存貨周轉天數 (天) | 355.283 | 183.743 | 62.467 | 38.635 | 100.751 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 06/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
